Publication | Closed Access

Early skin toxicity predicts better outcomes, and early tumor shrinkage predicts better response after cetuximab treatment in advanced colorectal cancer

Gastrointestinal OncologyEarly Tumor ShrinkageMedicineCancer ManagementColorectal CancerPathologyDermatologyAdvanced Colorectal CancerCancer TreatmentOncologyRadiation OncologyEarly Skin ToxicityCancer Research